Nhazi
Viekira Pak bụ ihe nchịkọta ọgwụ eji agwọ ọrịa na-adịghị ala ala nke C (HCV) . Ụlọ ahụ gụnyere otu Technivie ọgwụ ejikọta ahazi (ombitasvir + paritaprevir + ritonavir) tinyere nkwonkwo ọgwụ dasabuvir.
Ombitasvir ọgwụ ọjọọ, paritaprevir na dasabuvir bụ ndị na-eme antivirals (DAA) nke na-egbochi ntinyeghachi nje ahụ.
A na-ejikarị ọgwụ ọgwụ ritonavir eme ihe, nke a na-ejikarị mee ihe na nje HIV , iji mee ka ọnụ ọgụgụ ọgwụ nke paritaprevir dịkwuo elu .
Viekira Pak na-abụkarị, ma ọ bụghị mgbe niile, na-ejikọta ya na ribavirin na ọ dịghị mkpa ka e were ya na interferon na- egbuke egbuke (peg-interferon).
Viekira Pak kwadoro na December 19, 2014 site na US Food and Drug Administration (FDA) maka ndị okenye 18 afọ ma ọ bụ karịa na ọrịa HCV genotypes 1, gụnyere ndị nwere cirrhosis akwụ ụgwọ (nke imeju ka na-arụ ọrụ) na imeju imeju. Maka ndị nwere ọrịa cirrhosis, ndị Viekira Pak adịghị akwado.
A kọrọ na Viekira Pak na-enwe ọgwụgwọ dịka pasent 95 ma ọ bụ karịa, na ọ bụ nanị pasent 2 nke ndị ọrịa na-akwụsị usoro ọgwụgwọ n'ihi ekweghị ekwe. Okwesiri ka eji ya na ndi ozo nwere nje HIV / HCV .
Ọgwụgwọ
Mbadamba nkume abụọ nke mbadamba nkume nke ombitasvir + paritaprevir + ritonavir (25mg / 150mg / 100mg) were otu kwa ụbọchị na nri, tinyere otu tebụl nke dasabuvir iri ugboro abụọ kwa ụtụtụ na mgbede na nri.
Mbadamba mbadamba ahụ na-abanye na ngwugwu kwa ụbọchị, site na ntuziaka dosing gụnyere na igbe ọ bụla. Mbadamba nkume a na-etinye na ya bụ pink, ihe nkiri na-ekpuchi ma jiri ya rụọ "AV1", ebe mbadamba dasabuvir bụ agba aja aja, nke a na-ekiri ihe nkiri ma jupụta "AV2".
Na-akọwa ndụmọdụ
A na-etinye Viekira Pak n'usoro ọmụmụ nke ọnwa 12 ruo 24, dịka ọ na-atụ aro ndị a:
- Genotype 1a na-enweghị cirrhosis: Viekira Pak na ribavirin maka izu iri na abụọ
- Genotype 1a na cirrhosis: Viekira Pak na ribavirin maka izu iri abụọ na anọ
- Genotype 1b na-enweghị cirrhosis: Viekira Pak nanị maka izu iri na abụọ
- Genotype 1b na-enweghị cirrhosis: Viekira Pak na ribavirin maka izu 24
Nye ndị ọrịa na-atụgharị ọrịa imeju, Viekira Pak nwere ike were ya na ribavirin maka izu iri abụọ na anọ maọbụrụ na ọrụ ịba ahụ (imeju) bụ nkịtị na fibrosis (ụkọ) bụ obere.
Mmetụta Na-agakarị
Ihe mmetụta kachasị emetụta metụtara ojiji nke Viekira Pak (ime ihe ruru 10% nke ndị ọrịa) bụ:
- Ike ọgwụgwụ
- Nausea
- Ọgbu anụahụ
- Akpụkpọ ahụ
- Mkpụrụ obi
- Ike na ike ọgwụgwụ
Mmekọrịta ọgwụ ọjọọ
A ga-ezere ihe ndị a mgbe ị na-eji Viekira Pak:
- Ndị na-achọpụta ihe na-emepụta ihe: carbamazepine, phenytoin, phenobarbital
- Antihyperlipidemics (ejiri iji belata lipid etoju na ọbara): gemfibrozil
- Ngwá ọgwụ anti-arrhythmia: pimozide
- Cholesterol-ịdọrọ ọgwụ: lovastatin, simvastatin
- Mmiri ọgwụ na-arụ ọrụ Erectile: Viagra (sildenafil)
- Nri nke Ergot (eji agwọ isi na migraines): ergotamine, dihydroergotamine, ergonovine, methylergonovine
- Ethinyl estradiol (estrogen nke nwoke mere)
- Ọgwụ nje HIV : Sustiva (efavirenz) , Atripla (efavirenz + tenofovir + emtricitabine)
- Ngwọrọgwu hypotension: alfuzosin
- Mcobutin, Rifater, Rifamate, Rimactane, Rifadin, Priftin na Rifampin ọgwụ.
- Nzube: triazolam, ọnụ midazolam
Nkwekọrịta na Ntụle
Maka ndị ọrịa na-adịghị mma na-adịghị ahụkebe, Viekira Pak adịghị atụ aro ya. Viekira Pak na-eme ka a ghara iji ya mee ihe maka ndị ọrịa na-arịa ọrịa hepatic dị oké njọ.
A na-emegidekwa Viekira Pak na-eji ya eme ihe na ọrịa na-eme ka a na-akpọ ritonavir (gụnyere Stevens-Johnson Syndrome, nke nwere ike ịnweta ndụ, mmeghachi omume mkparụ niile).
Viekira Pak na-eme ka a ghara iji ya mee ihe na ndị inyom dị ime mgbe eji yabavirin.
A na-atụ aro na a ga-enyocha ụmụ nwanyị niile na-amụ nwa kwa ọnwa maka afọ ime n'oge ọgwụgwọ. A na-atụ aro ka onye ọrịa ahụ na onye òtù ọlụlụ ya nyere ma ọ dịkarịa ala ụzọ abụọ na-enweghị ọgwụgwọ nke ime mgbochi ime, nakwa na a ga-eji ha n'oge ọgwụgwọ na ọnwa isii mgbe e mesịrị.
Isi:
Nchịkwa nri na ọgwụgwọ US (FDA). "FDA kwadoro Viekira Pak ịgwọ ọrịa ịba ọcha n'anya C." Silver Spring, Maryland; pịa ntọhapụ nyere December 19, 2014.